# Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance), Division 3.1.3.6.2.1: Where an ATE is not available for an individual ingredient of the mixture, but available information, such as that listed below, can provide a derived conversion value such as those laid out in Table 3.1.2, the formula in section 3.1.3.6.1 shall be applied.

Extent: E+W+S+N.I.

This includes evaluation of:
(a) extrapolation between oral, dermal and inhalation acute toxicity estimates. Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;
(b) evidence from human exposure that indicates toxic effects but does not provide lethal dose data;
(c) evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or
(d) data from closely analogous substances using structure/activity relationships.
This approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.

---
Source: https://www.legislation.gov.uk/eur/2008/1272/annex/I/division/3/division/3.1/division/3.1.3/division/3.1.3.6/division/3.1.3.6.2/division/3.1.3.6.2.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2008-1272/annex-I/division-3/division-3.1/division-3.1.3/division-3.1.3.6/division-3.1.3.6.2/division-3.1.3.6.2.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

